Page 12 - Expanded Access Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ATARA Biotherapeutics (ATRA) and Pierre Fabre Laboratories Announce Publication of Phase 3 ALLELE Tab-cel Data

ATARA Biotherapeutics (ATRA) and Pierre Fabre Laboratories Announce Publication of Phase 3 ALLELE Tab-cel Data
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDana farber cancer instituteSusan prockopPrix galienPascal touchonAtara biotherapeutics incAmerican society of hematologyAccess programEuropean unionDrug administrationAmerican society of clinical oncologyEuropean commissionPierre fabre laboratoriesChief executive officerLancet oncologyExpanded access program

Cereno Scientific is granted Expanded Access by the FDA to drug candidate CS1 for rare disease pulmonary arterial hypertension

Cereno Scientific , a company developing innovative treatments for common and rare cardiovascular disease, today announced that the company has been granted approval by the FDA for Expanded Access,.

United statesVastra gotalands lanKendall squareRaymond benzaCereno expanded access programIr communicationsAccess programClinical steering committeeCereno scientific incMount sinai health systemUniversity of michiganCereno scientificNasdaq first northExpanded accessExpanded access programExtended access program

RedHill Biopharma Announces Closing of $8 Million Registered Direct Offering

/PRNewswire/ RedHill Biopharma Ltd. (NASDAQ: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has closed.

United kingdomNew yorkUnited statesRedhill biopharmaAdi frishCompany american depositary shares adssRedhill biopharma ltdCorporate business developmentCompany expanded access programProduct development pipelineCompany annual report on formExchange commissionHc wainwright coAmerican depositary sharesSecurities actHill biopharma

RedHill Biopharma Announces $8 Million Registered Direct Offering

/PRNewswire/ RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has entered.

United kingdomNew yorkUnited statesAdi frishRedhill biopharmaCompany american depositary shares adssCompany expanded access programPrnewswire redhill biopharma ltdRedhill biopharma ltdCompany annual report on formExchange commissionProduct development pipelineHc wainwright coCorporate business developmentHill biopharmaAmerican depositary shares

Zevra Therapeutics Receives FDA Acceptance of Resubmission of NDA for Arimoclomol as a Treatment for Niemann-Pick Disease Type C

Zevra Therapeutics Receives FDA Acceptance of Resubmission of NDA for Arimoclomol as a Treatment for Niemann-Pick Disease Type C
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

David schullNichol ochsnerNeilf mcfarlaneIgnacio guerrero rosZevra therapeutics incEuropean medicines agencyCompany expanded access programExchange commissionDrug administrationNew drug applicationPrescription drug user fee actChief executive officerOrphan drugFast trackBreakthrough therapyRare pediatric disease